Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Mittelman

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Clinical Lymphoma|October 15, 2003
The implications of anemia in multiple myelomaMoshe Mittelman
Harefuah|September 1, 2007
[Residency: in the hospital or in the community?]Moshe Mittelman
Harefuah|March 3, 2024
[TRANSLATIONAL MEDICINE IN MALIGNANT HEMATOLOGY]Moshe Mittelman
Haematologica|April 16, 2026
TP53 mutation analysis in myelodysplastic syndromes - long or short read sequencing?Moshe Mittelman, Liran Shlush
European Journal of Internal Medicine|November 4, 2004
Presentations at professional meetings: notes, suggestions and tips for speakersMichael Hoffman, Moshe Mittelman
Haematologica|January 22, 2026
Rethinking the effectiveness of hypomethylating agents in myelodysplastic syndromes: the 50%-2-year wallHoward Oster, Moshe Mittelman
Frontiers in Oncology|September 30, 2024
How we diagnose Myelodysplastic syndromesHoward S Oster, Moshe Mittelman
Blood Cells, Molecules & Diseases|November 14, 2019
Gaucher disease, myelodysplastic syndrome and ICUSRosa Ruchlemer, Moshe Mittelman, Ari Zimran
Oncology|October 26, 2005
Beyond anaemia management: evolving role of erythropoietin therapy in neurological disorders, multiple myeloma and tumour hypoxia modelsMarc Boogaerts, Moshe Mittelman, Peter Vaupel
Mediterranean Journal of Hematology and Infectious Diseases|July 14, 2018
Thrombocytopenia in Patients with Myelodysplastic Syndromes: Still an Unsolved ProblemMay Basood, Howard S Oster, Moshe Mittelman
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Clinical Lymphoma|October 15, 2003
The implications of anemia in multiple myelomaMoshe Mittelman
Harefuah|September 1, 2007
[Residency: in the hospital or in the community?]Moshe Mittelman
Harefuah|March 3, 2024
[TRANSLATIONAL MEDICINE IN MALIGNANT HEMATOLOGY]Moshe Mittelman
Haematologica|April 16, 2026
TP53 mutation analysis in myelodysplastic syndromes - long or short read sequencing?Moshe Mittelman, Liran Shlush
European Journal of Internal Medicine|November 4, 2004
Presentations at professional meetings: notes, suggestions and tips for speakersMichael Hoffman, Moshe Mittelman
Haematologica|January 22, 2026
Rethinking the effectiveness of hypomethylating agents in myelodysplastic syndromes: the 50%-2-year wallHoward Oster, Moshe Mittelman
Frontiers in Oncology|September 30, 2024
How we diagnose Myelodysplastic syndromesHoward S Oster, Moshe Mittelman
Blood Cells, Molecules & Diseases|November 14, 2019
Gaucher disease, myelodysplastic syndrome and ICUSRosa Ruchlemer, Moshe Mittelman, Ari Zimran
Oncology|October 26, 2005
Beyond anaemia management: evolving role of erythropoietin therapy in neurological disorders, multiple myeloma and tumour hypoxia modelsMarc Boogaerts, Moshe Mittelman, Peter Vaupel
Mediterranean Journal of Hematology and Infectious Diseases|July 14, 2018
Thrombocytopenia in Patients with Myelodysplastic Syndromes: Still an Unsolved ProblemMay Basood, Howard S Oster, Moshe Mittelman
Pageof 12